Cover Image

Efficacy of tetravalent dengue vaccine: A systematic review and meta-analysis

Dengue is one of the neglected tropical diseases caused by flavivirus. Live-attenuated tetravalent vaccine is launched for the age group of 9-45 years. It is given in three doses schedule. Eleven studies were included in meta-analysis by following PRISMA guidelines. Healthy persons in the age group...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ashish Wasudeo Khobragade (Author), Dilip D Kadam (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A recombinant live attenuated tetravalent vaccine for the prevention of dengue
by: Bruno Guy, et al.
Published: (2017)

The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017)

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination
by: Claire Vigne, et al.
Published: (2017)

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City
by: Shibadas Biswal, et al.
Published: (2021)

Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines.
by: Philip K Russell, et al.
Published: (2016)

Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).
by: Claire Y-H Huang, et al.
Published: (2013)

A case-control study to determine the effectiveness of a tetravalent dengue vaccine in the state of Paraná, Brazil
by: José Cássio de Moraes, et al.
Published: (2022)

Development and evaluation of a tetravalent botulinum vaccine
by: Dan-Yang Shi, et al.
Published: (2022)

Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials.
by: Sophia Gailhardou, et al.
Published: (2016)

Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003).
by: Laura J White, et al.
Published: (2021)

Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates.
by: Fiona R Strouts, et al.
Published: (2016)

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.
by: Stephen S Whitehead, et al.
Published: (2017)

Prevalence of stress and insomnia among health care workers in India during COVID-19 pandemic: A systematic review and meta-analysis
by: Ashish W Khobragade, et al.
Published: (2023)

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions
by: Philippe Moris, et al.
Published: (2019)

Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
by: Scott B. Halstead
Published: (2018)

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial
by: Mark Turner, et al.
Published: (2020)

How India has managed the COVID-19 first and second waves?
by: Rahul Pal, et al.
Published: (2022)

Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype.
by: Stefan W Metz, et al.
Published: (2018)

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults
by: Susan B. Manoff, et al.
Published: (2019)

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
by: Sanford R Kimmel
Published: (2008)

Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
by: Vianney Tricou, et al.
Published: (2023)

The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules
by: Eduardo Lazcano-Ponce, et al.
Published: (2018)

Dengue infection in India: A systematic review and meta-analysis.
by: Parasuraman Ganeshkumar, et al.
Published: (2018)

Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines
by: Paolo Bonanni, et al.
Published: (2020)

Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis
by: Rui Lin, et al.
Published: (2023)

Clinical predictors of severe dengue: a systematic review and meta-analysis
by: Tsheten Tsheten, et al.
Published: (2021)

Myocarditis manifestations in dengue cases: A systematic review and meta-analysis
by: Mokanpally Sandeep, et al.
Published: (2023)

Carica papaya extract in dengue: a systematic review and meta-analysis
by: Senaka Rajapakse, et al.
Published: (2019)

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
by: Ngoc Huu Tran, et al.
Published: (2019)

Human papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis
by: Romina A Tejada, et al.
Published: (2017)

Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis.
by: Tiruneh Adane, et al.
Published: (2021)

Environmental methods for dengue vector control - A systematic review and meta-analysis.
by: Claudia Buhler, et al.
Published: (2019)

Rapid immunochromatographic tests for the diagnosis of dengue: a systematic review and meta-analysis
by: Verónica Elizabeth Mata, et al.

Factors associated with dengue shock syndrome: a systematic review and meta-analysis.
by: Nguyen Tien Huy, et al.
Published: (2013)

Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis.
by: Leigh R Bowman, et al.
Published: (2016)

Is there a difference in the efficacy of COVID-19 vaccine in males and females? - A systematic review and meta-analysis
by: Zheng Zhu, et al.
Published: (2021)

Prevalence and laboratory analysis of malaria and dengue co-infection: a systematic review and meta-analysis
by: Manas Kotepui, et al.
Published: (2019)

Predictive markers for the early prognosis of dengue severity: A systematic review and meta-analysis.
by: Tran Quang Thach, et al.
Published: (2021)

Genetic variants associated with dengue hemorrhagic fever. A systematic review and meta-analysis
by: Mohammed Kanan, et al.
Published: (2024)

Efficacy and Safety of Vaccines After Conventional Treatments for Survival of Gliomas: A Systematic Review and Meta-Analysis
by: Elnaz Amanzadeh Jajin, et al.
Published: (2024)